Key facts
- It has raised $24.7M across 2 recorded rounds; the latest was Early Stage VC ($16.7M) in Apr 2025.
- Notable investors include Vensana Capital.
- Rampart IC has filed 2 Form Ds with the SEC since 2020, most recently May 2025 ($16.7M sold to 13 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Rampart IC
Funding rounds
2 roundsAbout Rampart IC
Developer of a fully adjustable and portable healthcare system designed to provide full-bodied radiation protection. The company's medical device is made of clear, lead-infused acrylic panels that block the radiation from reaching the operator during the catheterization procedures, enabling medical professionals to mitigate orthopedic risk by reducing the need for heavy aprons.
- Sector
- Healthcare
- HQ
- Birmingham, AL, United States
- Founded
- 2014
- Employees
- 36
- Website
- rampart.com/
- Ownership
- Privately Held (backing)
Rampart IC doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rampart IC shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rampart IC in its N-PORT filings yet. We sweep new filings monthly.